Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Edwards Lifesciences Corp receives CE Mark in Europe for valve-in-valve procedures using the SAPIEN XT transcatheter heart valve


Wednesday, 5 Feb 2014 09:25am EST 

Edwards Lifesciences Corp:Says it has received CE Mark in Europe for valve-in-valve procedures using the SAPIEN XT transcatheter heart valve, providing a minimally invasive treatment option for patients whose surgical mitral or aortic valves require replacement, and who are at extreme risk for surgery. 

Company Quote

130.18
-0.27 -0.21%
11:54am EDT